Johnson & Johnson (J&J) said that it had agreed to pay $181 million to settle consumer fraud claims by 36 U.S. states and the District of Columbia for improperly marketing its Risperdal antipsychotic drug for unapproved uses.
J & J...
Johnson & Johnson (J&J) said that it had agreed to pay $181 million to settle consumer fraud claims by 36 U.S. states and the District of Columbia for improperly marketing its Risperdal antipsychotic drug for unapproved uses.
J & J...
August 8, 2012 - The New York Times reported that medical mistakes may be responsible for as many as 200,000 deaths each year in the U.S, making...
The U.S. Consumer Product Safety Commission, in cooperation with Sherwin-Williams announced a voluntary recall of several paints in various stores. There have been complaints of leaking cans, which can cause a fire hazard, according to the...